Radiopharmaceuticals Market Research Reports & Industry Analysis
A radiopharmaceutical, which involves the use of radioactive agents in vivo to diagnose or treat specific diseases and conditions, generally consists of two components which determine its characteristics and clinical potential. The most common diagnostic molecular imaging agents use radioactive isotopes as the signal source. A radioactive isotope -- a radioisotope or radionuclide -- is a natural or artificially created isotope with an unstable nucleus that decays -- emitting alpha or beta particles, positrons, or gamma rays. As it decays, it loses mass and energy, until a stable isotope develops. For most elements, both stable and radioactive isotopes are known.
Examples of radioisotopes commonly combined with pharmaceutically-active molecules to form radiopharmaceuticals include technetium-99m, gallium-67, Iodine-123, Iodine-13, Thallium-201, Fluorine-18, and Indium-111.
A number of SPECT radiopharmaceuticals incorporate antibody and peptide formulations that can be targeted to specific tissue receptors, allowing one to discriminate healthy from diseased tissue with a high confidence level. However, the more specific the targeting agent is, the more difficult it is to interpret its position anatomically, since there are fewer landmarks.
Radiopharmaceuticals Industry Research & Market Reports
-
Europe Radiopharmaceutical Theranostics Market Forecast to 2028 -Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and ... Read More
-
Global Oncology Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029
... (2023-2029). This report studies the global Oncology Radiopharmaceutical production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for Oncology Radiopharmaceutical, and provides market size (US$ ... Read More
-
Global Oncology Radiopharmaceutical Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This ... Read More
-
Asia Pacific Radiopharmaceutical Theranostics Market Forecast to 2028 -Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic ... Read More
-
Global Oncology Radiopharmaceutical Market Growth 2023-2029
... % from 2023 to 2029. United States market for Oncology Radiopharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China ... Read More
-
Global Radiotheranostics Market Size study & Forecast, by Radioisotope (Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90, Others), by Approach (Targeted Therapeutic, Targeted Diagnostic), by Application (Oncology, Non Oncology) by and Regional Analysis, 2023-2030
... Market is valued at approximately USD 7.51 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.49% over the forecast period 2023-2030. Radiotheranostics refers to the field of ... Read More
-
MEA Radiopharmaceuticals Market - Industry Trends and Forecast to 2030
... CAGR of 5.1% during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 ... Read More
-
APAC Radiopharmaceuticals Market - Industry Trends and Forecast to 2030
... during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market ... Read More
-
Global Radiopharmaceuticals Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... Radiopharmaceuticals are unique medicinal formulations containing radioisotopes that are used in major clinical areas, and monitored via specific imaging devices, for diagnosis and/or therapy. Market Overview: The latest research study on the global Radiopharmaceuticals market ... Read More
-
NA Radiopharmaceuticals Market - Industry Trends and Forecast to 2030
... 8.1% during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. ... Read More
-
Global Radiopharmaceuticals Market - Industry Trends and Forecast to 2030
... during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market ... Read More
-
Global Diagnostic Radiopharmaceuticals Market Research Report 2023(Status and Outlook)
... medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases. North ... Read More
-
Global Radiopharmaceuticals Market Report and Forecast 2023-2031
... value is anticipated to grow at a CAGR of 7.50% during the forecast period of 2023-2031 to achieve a value of USD 9.53 billion by 2031. Radiopharmaceuticals: Introduction Radiopharmaceuticals, also known as radioactive drugs or ... Read More
-
Global Lutetium-177 Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... Lu-177 with numerous biologically active compounds. Market Overview: The latest research study on the global Lutetium-177 market finds that the global Lutetium-177 market reached a value of USD 65.25 million in 2022. It’s expected that ... Read More
-
Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028
... to reach USD 9.4 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 11.3% during the forecast period. Growth in the nuclear medicine market can primarily be attributed to factors such ... Read More
-
Saudi Arabia Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... Analysis and Industry Forecast, 2023-2032 The Saudi Arabia radiopharmaceuticals market is projected to register a healthy CAGR during the forecast period. The market growth is attributed to increasing prevalence of cancer, opening of new diagnostic ... Read More
-
Brazil Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The radiopharmaceuticals market in Brazil is anticipated to experience considerable development over the forecast period. The market is witnessing a surge for radiopharmaceuticals due to factors such as increased prevalence of ... Read More
-
Germany Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 Radiopharmaceuticals are drug-producing compounds of contaminated materials that are utilized in medical imaging and also cancer cells treatments. They are carried out intravenously to people for detecting and treating malignant as ... Read More
-
South Korea Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... Analysis and Industry Forecast, 2023-2032 The radiopharmaceutical industry has seen substantial development over the previous years, particularly with technical advancements in the medical market that enable much better medical diagnosis as well as treatments of ... Read More
-
Spain Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The rise in cancer, cardiovascular, and neurological illness prevalence, the rise in demand for medical imaging, and the rise in product approval for radiopharmaceuticals are the main factors driving the growth ... Read More
-
Italy Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The radiopharmaceuticals market in Italy is growing progressively due to the rising demand for radiopharmaceuticals for diagnostics, rehabs, and research study tasks. Radiopharmaceuticals are contaminated medicines that are used in nuclear ... Read More
-
Japan Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 Japan is one of the most appealing markets for medical imaging and radiopharmaceuticals. The radiopharmaceuticals market is experiencing a rise in popularity because of increasing recognition amongst both individuals and medical ... Read More
-
Mexico Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The Mexico radiopharmaceuticals market is expected to witness a favorable growth during the forecast period. With the rise in investments in R&D of radiopharmaceuticals for clinical and restorative applications, the market ... Read More
-
China Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The radiopharmaceuticals market has actually expanded substantially over the past years with the surge in the incidence of cancer cells, cardiovascular diseases, as well as other conditions worldwide. In terms of ... Read More
-
France Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The France Radiopharmaceuticals Market is a quickly expanding, specialized company with an estimated market value of EUR8.4 billion in 2020. Radiopharmaceuticals are drugs which contain radioactive aspects and have both analysis ... Read More
Research Assistance
